LpxH靶向抗菌药物研究进展
Research progress on LpxH-targeted antibacterial drugs
-
摘要: 尿苷二磷酸-2, 3-二酰基葡糖胺焦磷酸水解酶(UDP-2, 3-diacylglucosamine pyrophosphate hydrolase, LpxH) 是革兰阴性菌的脂质A (lipid A) 生物合成途径中的关键酶。由于脂质A作为脂多糖(lipopolysaccharide, LPS) 的必要组成成分, 在革兰阴性菌中参与着重要的生物学功能, LpxH被认为是抗菌药物研究的重要靶标之一。本文从LpxH的功能与结构出发, 对目前已报道的LpxH抑制剂进行了系统总结和分析, 并对未来的研究方向进行了展望。本综述将为LpxH抑制剂的设计提供思路, 有助于LpxH靶向的新型抗菌药物的研发。Abstract: UDP-2, 3-diacylglucosamine pyrophosphate hydrolase (LpxH) is a key enzyme in the lipid A biosynthesis pathway of Gram-negative bacteria. Lipid A is an indispensable component of lipopolysaccharide (LPS), and LPS plays an important biological function in Gram-negative bacteria. Therefore, LpxH is considered one of the important targets in the research of antibacterial drugs. Based on the function and structure of LpxH enzyme, this review systematically summarizes and analyzes the currently reported LpxH inhibitors, and offers perspectives on future research directions. This review will provide ideas for the design of LpxH inhibitors and contribute to the development of new antibacterial drugs targeting LpxH.
下载: